carcinoma papilífero familiar de tireóide - Faculdade de Medicina ...

19. Sippel SR, Caron RN, Clark OH. An evidence-based approach to familial
nonmedullary thyroid cancer:screening, clinical management, and follow-up.
Word J Surg 2007;31:924-933.
20. Nódulos de tireóide e cancer diferenciadode tireóide: Consenso brasileiro.
Arq Bras Endocrinol Metab 2007;51/5:867-93.
21. Triponez F, Wong M, Sturgeon C, Caron N, Ginzinger DG, Segal MR, et al.
Does familial non-medullary thyroid cancer adversely affect survival? World
J Surg 2006;30:787-93.
22. Hemminki K, Charis E, Chen B. Familial risks for nonmedullary thyroid
cancer. J Clin Endocrinol Metab 2005;90:5747-53.
23. Musholt TJ, Musholt PB, Petrich T, Oetting G, Knapp WH, Klempnauer J.
Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical
features and surgical treatment. World J Surg 2000;24:1409-17.
24. Alsanea O. Familial nommedullary thyroid cancer. Curr Treat Options Oncol
2000;1:345-51.
25. Cetta F, Curia MC, Montalto G, et al. Thyroid carcinoma usually occurs in
patients with familial adenomatous polyposis in the absence of biallelic
inactivation of the adenomatous polyposis coli gene. J Clin Endocrinol
Metab. 2001;86:427-432.
26. Stratakis CA, Courcoutsakis NA, Abati A, et al. Thyroid gland abnormalities
in patients with the syndrome of spotty skin pigmentation, myxomas,
endocrine overactivity, and schwannomas (Carney complex). J Clin
Endocrinol Metab. 1997;82:2037-2043.
61